This was the first event in our 2021 Webinar Wednesday Series. Throughout this series, we will be hosting a live webinar every other Wednesday evening at 7 PM about various topics of interest and importance in our community. To watch one of our previous webinars, click here.

About This Webinar

This webinar was held on Wednesday, January 20 at 7 PM.

Creating the next generation of therapies for hemophilia has had its share of successes and challenges. During this webinar, President & CEO of Sigilon Therapeutics, Rogerio Vivaldi, M.D., MBA, discussed the history of what has been done, what lessons have been learned, and how Sigilon is using the power of the cell as a potential therapy for people with bleeding disorders.

This webinar was supported by Sigilon Therapeutics.